Freespira
Simon Thomas is President of Freespira. He is a proven leader with experience developing and bringing to the market powerful new medical devices and treatments. Simon joined at Freespira’s founding and in the years since has led product development, clinical studies, quality, biostatistics, finance, operations, and regulatory approvals, including the company’s two Food and Drug Administration clearances. Before Freespira, he led engineering, research, and development, QA/RA, and operations for a number of successful medical technology companies.
Freespira
Freespira® is an FDA-cleared digital therapeutic proven to significantly reduce or eliminate Panic Disorder and PTSD symptoms by training users to normalize respiratory irregularities in just 28 days.